Related Experiment Video
Updated: May 28, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Cannabis use across the menstrual cycle: The impact of negative affect and cannabis use motives
Paige E Morris1, Paul L Soto1, Julia D Buckner1
1Louisiana State University, Department of Psychology, 236 Audubon Hall, Baton Rouge, LA 70803, USA.
Abstract:
Women experience greater state negative affect (NA) and physical symptoms during the premenstrual and menstrual phases of the menstrual cycle. Although women use more cannabis during the premenstrual and menstrual phases, no known studies have tested whether this is due to the synergistic effects of heightened NA and using cannabis to cope with increased NA or physical symptoms. This study tested whether state NA interacts with cannabis motives to predict more frequent cannabis use during these phases. Normally cycling women who endorsed past-month cannabis use (N = 40) retrospectively reported NA, cannabis use, and motives for 65 days. Cannabis use was more frequent during the premenstrual (but not menstrual) phase, and cannabis use to manage physical pain/discomfort (physical motives) was greater in the menstrual (but not premenstrual) phase. There were significant interactions between phase, state NA (depression and anger, in separate models), and coping and physical motives. Among women with higher state depression, coping motives were associated with more frequent cannabis use in the ovulatory phase whereas among women with lower state depression, coping motives were associated with more frequent cannabis use in the premenstrual phase. Among women with lower (but not higher) state anger, coping motives were associated with greater cannabis use frequency in the premenstrual phase. Among women with higher state NA, physical motives were associated with more frequent cannabis use in the menstrual (but not premenstrual) phase. Findings support that state NA interacts with motives during high-risk phases and is differentially related to more frequent cannabis use, which has important clinical implications.
More Related Videos
05:25Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Related Concept Videos
Disorders of the Female Reproductive System
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...